List of Tables
Table 1. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Kidney Cancer Diagnosis Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Kidney Cancer Diagnosis Market Competitive Situation by Manufacturers in 2024
Table 4. Global Kidney Cancer Diagnosis Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Kidney Cancer Diagnosis Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Kidney Cancer Diagnosis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Kidney Cancer Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Kidney Cancer Diagnosis, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Kidney Cancer Diagnosis, Product Type & Application
Table 12. Global Key Manufacturers of Kidney Cancer Diagnosis, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Kidney Cancer Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnosis as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Kidney Cancer Diagnosis Sales by Region (2020-2025) & (K Units)
Table 18. Global Kidney Cancer Diagnosis Sales Market Share by Region (2020-2025)
Table 19. Global Kidney Cancer Diagnosis Sales by Region (2026-2031) & (K Units)
Table 20. Global Kidney Cancer Diagnosis Sales Market Share by Region (2026-2031)
Table 21. Global Kidney Cancer Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2020-2025)
Table 23. Global Kidney Cancer Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Kidney Cancer Diagnosis Revenue Market Share by Region (2026-2031)
Table 25. North America Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
Table 27. North America Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
Table 28. North America Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
Table 32. Europe Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
Table 33. Europe Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Kidney Cancer Diagnosis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Kidney Cancer Diagnosis Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Kidney Cancer Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Kidney Cancer Diagnosis Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Kidney Cancer Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2020-2025)
Table 51. Global Kidney Cancer Diagnosis Sales (K Units) by Type (2026-2031)
Table 52. Global Kidney Cancer Diagnosis Sales Market Share by Type (2020-2025)
Table 53. Global Kidney Cancer Diagnosis Sales Market Share by Type (2026-2031)
Table 54. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2020-2025)
Table 57. Global Kidney Cancer Diagnosis Revenue Market Share by Type (2026-2031)
Table 58. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2020-2025)
Table 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2026-2031)
Table 60. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2020-2025)
Table 61. Global Kidney Cancer Diagnosis Sales (K Units) by Application (2026-2031)
Table 62. Global Kidney Cancer Diagnosis Sales Market Share by Application (2020-2025)
Table 63. Global Kidney Cancer Diagnosis Sales Market Share by Application (2026-2031)
Table 64. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Kidney Cancer Diagnosis Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2020-2025)
Table 67. Global Kidney Cancer Diagnosis Revenue Market Share by Application (2026-2031)
Table 68. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2020-2025)
Table 69. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2026-2031)
Table 70. Myriad Genetics Inc. Company Information
Table 71. Myriad Genetics Inc. Description and Business Overview
Table 72. Myriad Genetics Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Myriad Genetics Inc. Kidney Cancer Diagnosis Product
Table 74. Myriad Genetics Inc. Recent Developments/Updates
Table 75. NeoGenomics Laboratories Company Information
Table 76. NeoGenomics Laboratories Description and Business Overview
Table 77. NeoGenomics Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. NeoGenomics Laboratories Kidney Cancer Diagnosis Product
Table 79. NeoGenomics Laboratories Recent Developments/Updates
Table 80. Thermo Fisher Scientific Inc. Company Information
Table 81. Thermo Fisher Scientific Inc. Description and Business Overview
Table 82. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Product
Table 84. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 85. Sysmex Corporation Company Information
Table 86. Sysmex Corporation Description and Business Overview
Table 87. Sysmex Corporation Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sysmex Corporation Kidney Cancer Diagnosis Product
Table 89. Sysmex Corporation Recent Developments/Updates
Table 90. Rosetta Genomics Company Information
Table 91. Rosetta Genomics Description and Business Overview
Table 92. Rosetta Genomics Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Rosetta Genomics Kidney Cancer Diagnosis Product
Table 94. Rosetta Genomics Recent Developments/Updates
Table 95. Illumina Inc. Company Information
Table 96. Illumina Inc. Description and Business Overview
Table 97. Illumina Inc. Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Illumina Inc. Kidney Cancer Diagnosis Product
Table 99. Illumina Inc. Recent Developments/Updates
Table 100. Abbott Laboratories Company Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Abbott Laboratories Kidney Cancer Diagnosis Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Roche Holding AG Company Information
Table 106. Roche Holding AG Description and Business Overview
Table 107. Roche Holding AG Kidney Cancer Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Roche Holding AG Kidney Cancer Diagnosis Product
Table 109. Roche Holding AG Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Kidney Cancer Diagnosis Distributors List
Table 113. Kidney Cancer Diagnosis Customers List
Table 114. Kidney Cancer Diagnosis Market Trends
Table 115. Kidney Cancer Diagnosis Market Drivers
Table 116. Kidney Cancer Diagnosis Market Challenges
Table 117. Kidney Cancer Diagnosis Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Kidney Cancer Diagnosis
Figure 2. Global Kidney Cancer Diagnosis Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Kidney Cancer Diagnosis Market Share by Type: 2024 & 2031
Figure 4. Immunohistochemical Test Product Picture
Figure 5. Complete Blood Count Test Product Picture
Figure 6. Urine Test Product Picture
Figure 7. Blood Chemistry Test Product Picture
Figure 8. Global Kidney Cancer Diagnosis Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Kidney Cancer Diagnosis Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Surgery Center
Figure 12. Global Kidney Cancer Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Kidney Cancer Diagnosis Market Size (2020-2031) & (US$ Million)
Figure 14. Global Kidney Cancer Diagnosis Sales (2020-2031) & (K Units)
Figure 15. Global Kidney Cancer Diagnosis Average Price (US$/Unit) & (2020-2031)
Figure 16. Kidney Cancer Diagnosis Report Years Considered
Figure 17. Kidney Cancer Diagnosis Sales Share by Manufacturers in 2024
Figure 18. Global Kidney Cancer Diagnosis Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Kidney Cancer Diagnosis Players: Market Share by Revenue in Kidney Cancer Diagnosis in 2024
Figure 20. Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Kidney Cancer Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
Figure 23. North America Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
Figure 24. United States Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
Figure 27. Europe Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
Figure 28. Germany Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Kidney Cancer Diagnosis Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Kidney Cancer Diagnosis Revenue Market Share by Region (2020-2031)
Figure 35. China Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
Figure 45. Latin America Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Kidney Cancer Diagnosis Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Kidney Cancer Diagnosis Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Kidney Cancer Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Kidney Cancer Diagnosis by Type (2020-2031)
Figure 55. Global Revenue Market Share of Kidney Cancer Diagnosis by Type (2020-2031)
Figure 56. Global Kidney Cancer Diagnosis Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Kidney Cancer Diagnosis by Application (2020-2031)
Figure 58. Global Revenue Market Share of Kidney Cancer Diagnosis by Application (2020-2031)
Figure 59. Global Kidney Cancer Diagnosis Price (US$/Unit) by Application (2020-2031)
Figure 60. Kidney Cancer Diagnosis Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
